Jake Nunn has over 25 years of experience in the life science industry as an investor, independent director, research analyst and investment banker. He had also spent decades in US healthcare portfolio management, financial analysis and other board roles.
| Rank | Company | # | |
|---|---|---|---|
| 991st |  |
OADS | $1.21m |
|
NEW ROLE: Non-Executive Director, Hexima | 07 Apr 2022 |
|
|
NEW ROLE: Non-Executive Director, OADS | 03 Nov 2020 |
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| 2021-06-30 | Other | 78,125 | $0.00 | Other | ||
| 2021-06-29 | Issued | 104,165 | $0.00 | Placement | ||
| 2021-06-29 | Issued | 208,330 | $0.00 | Placement | ||
| 2020-08-07 | Issued | 500,000 | $0.26 | $130,000 | Other |
